Brief: Orphazyme Gets Conditional Approval For Nasdaq Listing
Sept 18 (Reuters) - Orphazyme A/S ORPHA.CO :
* UPDATE ON LISTING ON NASDAQ
* RECEIVED CONDITIONAL APPROVAL FOR LISTING FROM NASDAQ
* LISTING IS CONDITIONAL UPON CO UPDATING ITS RISK
DESCRIPTION
Source text for Eikon: ID:nGNE2jXFG9
Further company coverage: ORPHA.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Strategic Partners A/S
See all newsBrief: Strategic Partners Reports H1 EBIT Loss Of DKK 1.0 Mln, Maintains FY Guidance
Brief: Strategic Partners Buys Three Retail Properties In Tilst
Brief: Strategic Partners Q1 EBIT Loss At DKK 0.6 Mln
Brief: Strategic Partners Buys DKK 3 Mln Of Shares In Gyldendal
Brief: Strategic Partners 9-month EBIT Loss DKK 1.7 Mln